Schaper Benz & Wise Investment Counsel’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-487
Closed -$255K 155
2025
Q1
$255K Buy
487
+7
+1% +$3.58K 0.02% 138
2024
Q4
$243K Sell
480
-204
-30% -$116K 0.02% 141
2024
Q3
$400K Sell
684
-235
-26% -$133K 0.03% 123
2024
Q2
$468K Buy
919
+37
+4% +$18.1K 0.04% 111
2024
Q1
$436K Buy
882
+1
+0.1% +$508 0.04% 115
2023
Q4
$464K Hold
881
0.04% 107
2023
Q3
$444K Hold
881
0.04% 107
2023
Q2
$423K Hold
881
0.04% 110
2023
Q1
$416K Hold
881
0.04% 108
2022
Q4
$467K Buy
881
+39
+5% +$20.7K 0.05% 102
2022
Q3
$425K Hold
842
0.05% 105
2022
Q2
$432K Buy
842
+241
+40% +$121K 0.04% 112
2022
Q1
$306K Hold
601
0.03% 130
2021
Q4
$302K Hold
601
0.02% 131
2021
Q3
$235K Hold
601
0.02% 121
2021
Q2
$241K Hold
601
0.02% 118
2021
Q1
$224K Hold
601
0.02% 117
2020
Q4
$211K Buy
+601
New +$201K 0.02% 118
2017
Q3
Sell
-1,900
Closed -$352K 114
2017
Q2
$352K Buy
+1,900
New +$333K 0.06% 96

Other funds holding UNH

Schaper Benz & Wise Investment Counsel's UNH Position: Q2 2025 in Review

Schaper Benz & Wise Investment Counsel sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 487 shares — an estimated $255K sold.

Schaper Benz & Wise Investment Counsel first reported a position in UNH in Q2 2017 and held it in 19 quarters. The position peaked at $468K in Q2 2024. 3,178 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Schaper Benz & Wise Investment Counsel reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Schaper Benz & Wise Investment Counsel sold 487 UnitedHealth shares in Q2 2025, an estimated $255K.
  • Schaper Benz & Wise Investment Counsel first reported a position in UnitedHealth in Q2 2017 and held it in 19 quarters.
  • Schaper Benz & Wise Investment Counsel's UnitedHealth position peaked at $468K in Q2 2024.
  • 3,178 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2025, filed 30 Jul 2025.